Olsen, J., Chandratre, S., Alsalamah, L., Merenich, D., Myers, K. A., & Chen, B. (2025). Combination of iron chelator deferoxamine and ABCG2 transporter inhibitor lapatinib for therapeutic enhancement of 5‐aminolevulinic acid. Wiley. https://doi.org/10.1111/php.70057
Cita Chicago Style (17a ed.)Olsen, Jordyn, Sharayu Chandratre, Lolwah Alsalamah, Daniel Merenich, Kenneth A. Myers, y Bin Chen. Combination of Iron Chelator Deferoxamine and ABCG2 Transporter Inhibitor Lapatinib for Therapeutic Enhancement of 5‐aminolevulinic Acid. Wiley, 2025. https://doi.org/10.1111/php.70057.
Cita MLA (9a ed.)Olsen, Jordyn, et al. Combination of Iron Chelator Deferoxamine and ABCG2 Transporter Inhibitor Lapatinib for Therapeutic Enhancement of 5‐aminolevulinic Acid. Wiley, 2025. https://doi.org/10.1111/php.70057.